Interaction of basal forebrain cholinergic neurons with the glucocorticoid system in stress regulation and cognitive impairment

Frontiers in Aging Neuroscience

Volumn 7, Issue MAR, 2015, Pages

  Paul, Saswati ^a   Jeon, Won Kyung ^b   Bizon, Jennifer L ^c   Han, Jung Soo ^a  

^a Konkuk University   (South Korea)

^b Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Aging; Basal forebrain; Cholinergic neuron; Glucocorticoid; Glucocorticoid receptor; Hippocampus; Stress

Indexed keywords

ACETYLCHOLINE; CHOLINERGIC RECEPTOR; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN;

AGING; ALZHEIMER DISEASE; CELL INTERACTION; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; COGNITION; COGNITIVE DEFECT; CORTICOSTERONE BLOOD LEVEL; DEMENTIA; FOREBRAIN; FRONTAL CORTEX; HIPPOCAMPUS; HORMONE RECEPTOR INTERACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MULTIPLE SCLEROSIS; NONHUMAN; PARASYMPATHETIC INNERVATION; PROTEIN PROTEIN INTERACTION; PYRAMIDAL NERVE CELL; REVIEW; SIGNAL TRANSDUCTION; STRESS;

EID: 84926353229     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2015.00043     Document Type: Review

References (169)

1. Aguilera, G. (2011). HPA axis responsiveness to stress: implications for healthy aging. Exp Gerontol 46, 90-95.
2. Anson, R.M., Cutler, R., Joseph, J.A., Yamagami, K., and Roth, G.S. (1992). The effects of aging on muscarinic receptor/G-protein coupling in the rat hippocampus and striatum. Brain Res 598, 302-306.
3. Arendt, T., Bigl, V., Arendt, A., and Tennstedt, A. (1983). Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease. Acta Neuropathol 61, 101-108.
4. Bartus, R.T. (2000). On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol 163, 495-529.
5. Bartus, R.T., Dean, R.L., 3rd, Beer, B., and Lippa, A.S. (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408-414.
6. Baskerville, K.A., Kent, C., Nicolle, M.M., Gallagher, M., and Mckinney, M. (2006). Aging causes partial loss of basal forebrain but no loss of pontine reticular cholinergic neurons. Neuroreport 17, 1819-1823.
7. Baxter, M.G., and Bucci, D.J. (2013). Selective immunotoxic lesions of basal forebrain cholinergic neurons: twenty years of research and new directions. Behav Neurosci 127, 611-618.
8. Baxter, M.G., Bucci, D.J., Gorman, L.K., Wiley, R.G., and Gallagher, M. (1995). Selective immunotoxic lesions of basal forebrain cholinergic cells: effects on learning and memory in rats. Behav Neurosci 109, 714-722.
9. Baxter, M.G., and Chiba, A.A. (1999). Cognitive functions of the basal forebrain. Curr Opin Neurobiol 9, 178-183.
10. Baxter, M.G., Gallagher, M., and Holland, P.C. (1999). Blocking can occur without losses in attention in rats with selective removal of hippocampal cholinergic input. Behav Neurosci 113, 881-890.
11. Baxter, M.G., Holland, P.C., and Gallagher, M. (1997). Disruption of decrements in conditioned stimulus processing by selective removal of hippocampal cholinergic input. J Neurosci 17, 5230-5236.
12. Berger-Sweeney, J., Heckers, S., Mesulam, M.M., Wiley, R.G., Lappi, D.A., and Sharma, M. (1994). Differential effects on spatial navigation of immunotoxin-induced cholinergic lesions of the medial septal area and nucleus basalis magnocellularis. J Neurosci 14, 4507-4519.
13. Bizon, J.L., Helm, K.A., Han, J.S., Chun, H.J., Pucilowska, J., Lund, P.K., and Gallagher, M. (2001). Hypothalamic-pituitary-adrenal axis function and corticosterone receptor expression in behaviourally characterized young and aged Long-Evans rats. Eur J Neurosci 14, 1739-1751.
14. Bodnoff, S.R., Humphreys, A.G., Lehman, J.C., Diamond, D.M., Rose, G.M., and Meaney, M.J. (1995). Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young and mid-aged rats. J Neurosci 15, 61-69.
15. Brayda-Bruno, L., Mons, N., Yee, B.K., Micheau, J., Abrous, D.N., Nogues, X., and Marighetto, A. (2013). Partial loss in septo-hippocampal cholinergic neurons alters memory-dependent measures of brain connectivity without overt memory deficits. Neurobiol Dis 54, 372-381.
16. Brureau, A., Zussy, C., Delair, B., Ogier, C., Ixart, G., Maurice, T., and Givalois, L. (2013). Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer's disease rat model. Neurobiol Aging 34, 1426-1439.
17. Bucci, D.J., Holland, P.C., and Gallagher, M. (1998). Removal of cholinergic input to rat posterior parietal cortex disrupts incremental processing of conditioned stimuli. J Neurosci 18, 8038-8046.
18. Calogero, A.E., Bernardini, R., Gold, P.W., and Chrousos, G.P. (1988). Regulation of rat hypothalamic corticotropin-releasing hormone secretion in vitro: potential clinical implications. Adv Exp Med Biol 245, 167-181.
19. Calogero, A.E., Kamilaris, T.C., Johnson, E.O., Tartaglia, M.E., and Chrousos, G. (1990). Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone. Endocrinology 127, 1574-1579.
20. Cavarsan, C.F., Avanzi, R.D., Queiroz, C.M., Xavier, G.F., Mello, L.E., and Covolan, L. (2011). m1 Acetylcholine Receptor Expression is Decreased in Hippocampal CA1 region of Aged Epileptic Animals. Aging Dis 2, 301-307.
21. Cestari, V., Rossi-Arnaud, C., Saraulli, D., and Costanzi, M. (2014). The MAP(K) of fear: from memory consolidation to memory extinction. Brain Res Bull 105, 8-16.
22. Chiba, A.A., Bushnell, P.J., Oshiro, W.M., and Gallagher, M. (1999). Selective removal of cholinergic neurons in the basal forebrain alters cued target detection. Neuroreport 10, 3119-3123.
23. Chudasama, Y., Dalley, J.W., Nathwani, F., Bouger, P., and Robbins, T.W. (2004). Cholinergic modulation of visual attention and working memory: dissociable effects of basal forebrain 192-IgG-saporin lesions and intraprefrontal infusions of scopolamine. Learn Mem 11, 78-86.
24. Clark, A.R. (2007). Anti-inflammatory functions of glucocorticoid-induced genes. Mol Cell Endocrinol 275, 79-97.
25. Coburn-Litvak, P.S., Tata, D.A., Gorby, H.E., Mccloskey, D.P., Richardson, G., and Anderson, B.J. (2004). Chronic corticosterone affects brain weight, and mitochondrial, but not glial volume fraction in hippocampal area CA3. Neuroscience 124, 429-438.
26. Colgin, L.L., Kubota, D., and Lynch, G. (2003). Cholinergic plasticity in the hippocampus. Proc Natl Acad Sci U S A 100, 2872-2877.
27. Conner, J.M., Chiba, A.A., and Tuszynski, M.H. (2005). The basal forebrain cholinergic system is essential for cortical plasticity and functional recovery following brain injury. Neuron 46, 173-179.
28. Conrad, C.D. (2008). Chronic stress-induced hippocampal vulnerability: the glucocorticoid vulnerability hypothesis. Rev Neurosci 19, 395-411.
29. Contestabile, A. (2011). The history of the cholinergic hypothesis. Behav Brain Res 221, 334-340.
30. Craig, L.A., Hong, N.S., Kopp, J., and Mcdonald, R.J. (2008). Emergence of spatial impairment in rats following specific cholinergic depletion of the medial septum combined with chronic stress. Eur J Neurosci 27, 2262-2271.
31. Craig, L.A., Hong, N.S., and Mcdonald, R.J. (2011). Revisiting the cholinergic hypothesis in the development of Alzheimer's disease. Neurosci Biobehav Rev 35, 1397-1409.
32. Dachir, S., Kadar, T., Robinzon, B., and Levy, A. (1997). Nimodipine's protection against corticosterone-induced morphological changes in the hippocampus of young rats. Brain Res 748, 175-183.
33. Davies, P., and Maloney, A.J. (1976). Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2, 1403.
34. Davis, K.L., and Mohs, R.C. (1982). Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine. Am J Psychiatry 139, 1421-1424.
35. De Kloet, E.R. (2008). About stress hormones and resilience to psychopathology. J Neuroendocrinol 20, 885-892.
36. De Kloet, E.R., Vreugdenhil, E., Oitzl, M.S., and Joels, M. (1998). Brain corticosteroid receptor balance in health and disease. Endocr Rev 19, 269-301.
37. Degroot, A., Wade, M., Salhoff, C., Davis, R.J., Tzavara, E.T., and Nomikos, G.G. (2004). Exposure to an elevated platform increases plasma corticosterone and hippocampal acetylcholine in the rat: reversal by chlordiazepoxide. Eur J Pharmacol 493, 103-109.
38. Drachman, D.A., Glosser, G., Fleming, P., and Longenecker, G. (1982). Memory decline in the aged: treatment with lecithin and physostigmine. Neurology 32, 944-950.
39. Drever, B.D., Riedel, G., and Platt, B. (2011). The cholinergic system and hippocampal plasticity. Behav Brain Res 221, 505-514.
40. Dumas, J.A., and Newhouse, P.A. (2011). The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation. Pharmacol Biochem Behav 99, 254-261.
41. Dutar, P., Bassant, M.H., Senut, M.C., and Lamour, Y. (1995). The septohippocampal pathway: structure and function of a central cholinergic system. Physiol Rev 75, 393-427.
42. Easton, A., Douchamps, V., Eacott, M., and Lever, C. (2012). A specific role for septohippocampal acetylcholine in memory? Neuropsychologia 50, 3156-3168.
43. Emala, C.W., Clancy, J., and Hirshman, C.A. (1997). Glucocorticoid treatment decreases muscarinic receptor expression in canine airway smooth muscle. Am J Physiol 272, L745-751.
44. Finkelstein, Y., Koffler, B., Rabey, J.M., and Gilad, G.M. (1985). Dynamics of cholinergic synaptic mechanisms in rat hippocampus after stress. Brain Res 343, 314-319.
45. Finsterwald, C., and Alberini, C.M. (2014). Stress and glucocorticoid receptor-dependent mechanisms in long-term memory: from adaptive responses to psychopathologies. Neurobiol Learn Mem 112, 17-29.
46. Flynn, D.D., Weinstein, D.A., and Mash, D.C. (1991). Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies. Ann Neurol 29, 256-262.
47. Fuchs, E., Flugge, G., Ohl, F., Lucassen, P., Vollmann-Honsdorf, G.K., and Michaelis, T. (2001). Psychosocial stress, glucocorticoids, and structural alterations in the tree shrew hippocampus. Physiol Behav 73, 285-291.
48. Funder, J.W. (1997). Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance. Annu Rev Med 48, 231-240.
49. Furay, A.R., Bruestle, A.E., and Herman, J.P. (2008). The role of the forebrain glucocorticoid receptor in acute and chronic stress. Endocrinology 149, 5482-5490.
50. Gallagher, M., Burwell, R.D., Kodsi, M.H., Mckinney, M., Southerland, S., Vella-Rountree, L., and Lewis, M.H. (1990). Markers for biogenic amines in the aged rat brain: relationship to decline in spatial learning ability. Neurobiol Aging 11, 507-514.
51. Gallagher, M., and Colombo, P.J. (1995). Ageing: the cholinergic hypothesis of cognitive decline. Curr Opin Neurobiol 5, 161-168.
52. Gallagher, M., Stocker, A.M., and Koh, M.T. (2011). Mindspan: lessons from rat models of neurocognitive aging. ILAR J 52, 32-40.
53. Gilad, G.M. (1987). The stress-induced response of the septo-hippocampal cholinergic system. A vectorial outcome of psychoneuroendocrinological interactions. Psychoneuroendocrinology 12, 167-184.
54. Gilad, G.M., Mahon, B.D., Finkelstein, Y., Koffler, B., and Gilad, V.H. (1985). Stress-induced activation of the hippocampal cholinergic system and the pituitary-adrenocortical axis. Brain Res 347, 404-408.
55. Groeneweg, F.L., Karst, H., De Kloet, E.R., and Joels, M. (2011). Rapid non-genomic effects of corticosteroids and their role in the central stress response. J Endocrinol 209, 153-167.
56. Hagan, J.J., Salamone, J.D., Simpson, J., Iversen, S.D., and Morris, R.G. (1988). Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularis. Behav Brain Res 27, 9-20.
57. Han, J.S., Bizon, J.L., Chun, H.J., Maus, C.E., and Gallagher, M. (2002). Decreased glucocorticoid receptor mRNA and dysfunction of HPA axis in rats after removal of the cholinergic innervation to hippocampus. Eur J Neurosci 16, 1399-1404.
58. Hatzinger, M., Brand, S., Herzig, N., and Holsboer-Trachsler, E. (2011). In healthy young and elderly adults, hypothalamic-pituitary-adrenocortical axis reactivity (HPA AR) varies with increasing pharmacological challenge and with age, but not with gender. J Psychiatr Res 45, 1373-1380.
59. Helm, K.A., Han, J.S., and Gallagher, M. (2002). Effects of cholinergic lesions produced by infusions of 192 IgG-saporin on glucocorticoid receptor mRNA expression in hippocampus and medial prefrontal cortex of the rat. Neuroscience 115, 765-774.
60. Helm, K.A., Ziegler, D.R., and Gallagher, M. (2004). Habituation to stress and dexamethasone suppression in rats with selective basal forebrain cholinergic lesions. Hippocampus 14, 628-635.
61. Hepler, D.J., Olton, D.S., Wenk, G.L., and Coyle, J.T. (1985). Lesions in nucleus basalis magnocellularis and medial septal area of rats produce qualitatively similar memory impairments. J Neurosci 5, 866-873.
62. Herman, J.P., Prewitt, C.M., and Cullinan, W.E. (1996). Neuronal circuit regulation of the hypothalamo-pituitary-adrenocortical stress axis. Crit Rev Neurobiol 10, 371-394.
63. Herman, J.P., Schafer, M.K., Young, E.A., Thompson, R., Douglass, J., Akil, H., and Watson, S.J. (1989). Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo pituitary-adrenocortical axis. J Neurosci 9, 3072-3082.
64. Hibberd, C., Yau, J.L., and Seckl, J.R. (2000). Glucocorticoids and the ageing hippocampus. J Anat 197 Pt 4, 553-562.
65. Hock, C., Maddalena, A., Raschig, A., Muller-Spahn, F., Eschweiler, G., Hager, K., Heuser, I., Hampel, H., Muller-Thomsen, T., Oertel, W., Wienrich, M., Signorell, A., Gonzalez-Agosti, C., and Nitsch, R.M. (2003). Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of A beta 42 in patients with Alzheimer's disease. Amyloid 10, 1-6.
66. Hortnagl, H., Berger, M.L., Havelec, L., and Hornykiewicz, O. (1993). Role of glucocorticoids in the cholinergic degeneration in rat hippocampus induced by ethylcholine aziridinium (AF64A). J Neurosci 13, 2939-2945.
67. Imperato, A., Puglisi-Allegra, S., Casolini, P., Zocchi, A., and Angelucci, L. (1989). Stress-induced enhancement of dopamine and acetylcholine release in limbic structures: role of corticosterone. Eur J Pharmacol 165, 337-338.
68. Issa, A.M., Rowe, W., Gauthier, S., and Meaney, M.J. (1990). Hypothalamic-pituitary-adrenal activity in aged, cognitively impaired and cognitively unimpaired rats. J Neurosci 10, 3247-3254.
69. Jacobson, L., and Sapolsky, R. (1991). The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev 12, 118-134.
70. Janisiewicz, A.M., Jackson, O., 3rd, Firoz, E.F., and Baxter, M.G. (2004). Environment-spatial conditional learning in rats with selective lesions of medial septal cholinergic neurons. Hippocampus 14, 265-273.
71. Joels, M. (2008). Functional actions of corticosteroids in the hippocampus. Eur J Pharmacol 583, 312-321.
72. Johnson, M. (2005). Corticosteroids: potential beta2-agonist and anticholinergic interactions in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2, 320-325; discussion 340-321.
73. Kalb, A., Von Haefen, C., Sifringer, M., Tegethoff, A., Paeschke, N., Kostova, M., Feldheiser, A., and Spies, C.D. (2013). Acetylcholinesterase inhibitors reduce neuroinflammation and - degeneration in the cortex and hippocampus of a surgery stress rat model. PLoS One 8, e62679.
74. Kaufer, D., Friedman, A., Seidman, S., and Soreq, H. (1998). Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393, 373-377.
75. Kile, J.P., and Turner, B.B. (1985). Serotonergic and cholinergic interaction in the regulation of pituitary-adrenal function in rats. Experientia 41, 1123-1127.
76. Kim, H.G., and Kim, K.L. (2007). Decreased hippocampal cholinergic neurostimulating peptide precursor protein associated with stress exposure in rat brain by proteomic analysis. J Neurosci Res 85, 2898-2908.
77. Kim, J.J., and Diamond, D.M. (2002). The stressed hippocampus, synaptic plasticity and lost memories. Nat Rev Neurosci 3, 453-462.
78. Klinkenberg, I., and Blokland, A. (2010). The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci Biobehav Rev 34, 1307-1350.
79. Lee, C.T., Ma, Y.L., and Lee, E.H. (2007). Serum- and glucocorticoid-inducible kinase1 enhances contextual fear memory formation through down-regulation of the expression of Hes5. J Neurochem 100, 1531-1542.
80. Lee, S.Y., Hwang, Y.K., Yun, H.S., and Han, J.S. (2012). Decreased levels of nuclear glucocorticoid receptor protein in the hippocampus of aged Long-Evans rats with cognitive impairment. Brain Res 1478, 48-54.
81. Lee, S.Y., Kim, M.S., and Han, J.S. (2013). Activation of NF-kappa κB signaling in the hippocampus without cholinergic input was aggravated by chronic stress. Soc. Neurosci. Abstr.
82. Leverenz, J.B., Wilkinson, C.W., Wamble, M., Corbin, S., Grabber, J.E., Raskind, M.A., and Peskind, E.R. (1999). Effect of chronic high-dose exogenous cortisol on hippocampal neuronal number in aged nonhuman primates. J Neurosci 19, 2356-2361.
83. Levin, E.D. (2013). Complex relationships of nicotinic receptor actions and cognitive functions. Biochem Pharmacol 86, 1145-1152.
84. Levy-Gigi, E., Szabo, C., Kelemen, O., and Keri, S. (2013). Association Among Clinical Response, Hippocampal Volume, and FKBP5 Gene Expression in Individuals with Posttraumatic Stress Disorder Receiving Cognitive Behavioral Therapy. Biol Psychiatry 74, 793-800.
85. Lewis, P.R., and Shute, C.C. (1967). The cholinergic limbic system: projections to hippocampal formation, medial cortex, nuclei of the ascending cholinergic reticular system, and the subfornical organ and supra-optic crest. Brain 90, 521-540.
86. Lewis, P.R., Shute, C.C., and Silver, A. (1967). Confirmation from choline acetylase analyses of a massive cholinergic innervation to the rat hippocampus. J Physiol 191, 215-224.
87. Lim, C.S., Hwang, Y.K., Kim, D., Cho, S.H., Banuelos, C., Bizon, J.L., and Han, J.S. (2011a). Increased interactions between PKA and NF-kappaB signaling in the hippocampus following loss of cholinergic input. Neuroscience 192, 485-493.
88. Lim, C.S., Kim, Y.J., Hwang, Y.K., Bañuelos, C., Bizon, J.L., and Han, J.S. (2011b). Decreased interactions in protein kinase A-Glucocorticoid receptor signaling in the hippocampus after selective removal of the basal forebrain cholinergic input. Hippocampus, DOI: 10.1002/hipo.20912.
89. Lund, P.K., Hoyt, E.C., Bizon, J., Smith, D.R., Haberman, R., Helm, K., and Gallagher, M. (2004). Transcriptional mechanisms of hippocampal aging. Exp Gerontol 39, 1613-1622.
90. Lupien, S., Lecours, A.R., Lussier, I., Schwartz, G., Nair, N.P., and Meaney, M.J. (1994). Basal cortisol levels and cognitive deficits in human aging. J Neurosci 14, 2893-2903.
91. Lupien, S.J., Mcewen, B.S., Gunnar, M.R., and Heim, C. (2009). Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 10, 434-445.
92. Maki, M., Matsukawa, N., Yuasa, H., Otsuka, Y., Yamamoto, T., Akatsu, H., Okamoto, T., Ueda, R., and Ojika, K. (2002). Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer disease. J Neuropathol Exp Neurol 61, 176-185.
93. Mark, G.P., Rada, P.V., and Shors, T.J. (1996). Inescapable stress enhances extracellular acetylcholine in the rat hippocampus and prefrontal cortex but not the nucleus accumbens or amygdala. Neuroscience 74, 767-774.
94. Marti, O., and Armario, A. (1997). Influence of Regularity of Exposure to Chronic Stress on the Pattern of Habituation of Pituitary-Adrenal Hormones, Prolactin and Glucose. Stress 1, 179-189.
95. Mcewen, B.S. (1999). Stress and hippocampal plasticity. Annu Rev Neurosci 22, 105-122.
96. Mcewen, B.S., and Wallach, G. (1973). Corticosterone binding to hippocampus: nuclear and cytosol binding in vitro. Brain Res 57, 373-386.
97. Mcewen, B.S., Weiss, J.M., and Schwartz, L.S. (1968). Selective retention of corticosterone by limbic structures in rat brain. Nature 220, 911-912.
98. Mcewen, B.S., Weiss, J.M., and Schwartz, L.S. (1969). Uptake of corticosterone by rat brain and its concentration by certain limbic structures. Brain Res 16, 227-241.
99. Mckay, L.I., and Cidlowski, J.A. (1998). Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. Mol Endocrinol 12, 45-56.
100. Mckinney, M., Coyle, J.T., and Hedreen, J.C. (1983). Topographic analysis of the innervation of the rat neocortex and hippocampus by the basal forebrain cholinergic system. J Comp Neurol 217, 103-121.
101. Medeiros, R., Kitazawa, M., Caccamo, A., Baglietto-Vargas, D., Estrada-Hernandez, T., Cribbs, D.H., Fisher, A., and Laferla, F.M. (2011). Loss of muscarinic M1 receptor exacerbates Alzheimer's disease-like pathology and cognitive decline. Am J Pathol 179, 980-991.
102. Mesulam, M. (2004). The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? Learn Mem 11, 43-49.
103. Mesulam, M.M., Mufson, E.J., Wainer, B.H., and Levey, A.I. (1983). Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience 10, 1185-1201.
104. Mishima, K., Iwasaki, K., Tsukikawa, H., Matsumoto, Y., Egashira, N., Abe, K., Egawa, T., and Fujiwara, M. (2000). The scopolamine-induced impairment of spatial cognition parallels the acetylcholine release in the ventral hippocampus in rats. Jpn J Pharmacol 84, 163-173.
105. Mizoguchi, K., Ikeda, R., Shoji, H., Tanaka, Y., Maruyama, W., and Tabira, T. (2009). Aging attenuates glucocorticoid negative feedback in rat brain. Neuroscience 159, 259-270.
106. Mizoguchi, K., Shoji, H., Ikeda, R., Tanaka, Y., Maruyama, W., and Tabira, T. (2008). Suppression of glucocorticoid secretion enhances cholinergic transmission in rat hippocampus. Brain Res Bull 76, 612-615.
107. Mizuno, T., and Kimura, F. (1997). Attenuated stress response of hippocampal acetylcholine release and adrenocortical secretion in aged rats. Neurosci Lett 222, 49-52.
108. Mora, F., Segovia, G., Del Arco, A., De Blas, M., and Garrido, P. (2012). Stress, neurotransmitters, corticosterone and body-brain integration. Brain Res 1476, 71-85.
109. Morris, M.C., and Rao, U. (2013). Cortisol response to psychosocial stress during a depressive episode and remission. Stress.
110. Muir, J.L., Page, K.J., Sirinathsinghji, D.J., Robbins, T.W., and Everitt, B.J. (1993). Excitotoxic lesions of basal forebrain cholinergic neurons: effects on learning, memory and attention. Behav Brain Res 57, 123-131.
111. Muller, M.B., Lucassen, P.J., Yassouridis, A., Hoogendijk, W.J., Holsboer, F., and Swaab, D.F. (2001). Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur J Neurosci 14, 1603-1612.
112. Murphy, E.K., Spencer, R.L., Sipe, K.J., and Herman, J.P. (2002). Decrements in nuclear glucocorticoid receptor (GR) protein levels and DNA binding in aged rat hippocampus. Endocrinology 143, 1362-1370.
113. Newhouse, P.A., Potter, A., Corwin, J., and Lenox, R. (1994). Age-related effects of the nicotinic antagonist mecamylamine on cognition and behavior. Neuropsychopharmacology 10, 93-107.
114. Newhouse, P.A., Sunderland, T., Tariot, P.N., Weingartner, H., Thompson, K., Mellow, A.M., Cohen, R.M., and Murphy, D.L. (1988). The effects of acute scopolamine in geriatric depression. Arch Gen Psychiatry 45, 906-912.
115. Newman, M.B., Nazian, S.J., Sanberg, P.R., Diamond, D.M., and Shytle, R.D. (2001). Corticosterone-attenuating and anxiolytic properties of mecamylamine in the rat. Prog Neuropsychopharmacol Biol Psychiatry 25, 609-620.
116. Nieves-Martinez, E., Haynes, K., Childers, S.R., Sonntag, W.E., and Nicolle, M.M. (2012). Muscarinic receptor/G-protein coupling is reduced in the dorsomedial striatum of cognitively impaired aged rats. Behav Brain Res 227, 258-264.
117. Nikzad, S., Vafaei, A.A., Rashidy-Pour, A., and Haghighi, S. (2011). Systemic and intrahippocampal administrations of the glucocorticoid receptor antagonist RU38486 impairs fear memory reconsolidation in rats. Stress 14, 459-464.
118. Notarianni, E. (2013). Hypercortisolemia and glucocorticoid receptor-signaling insufficiency in Alzheimer' s disease initiation and development. Curr Alzheimer Res 10, 714-731.
119. Nyakas, C., Luiten, P.G., Spencer, D.G., and Traber, J. (1987). Detailed projection patterns of septal and diagonal band efferents to the hippocampus in the rat with emphasis on innervation of CA1 and dentate gyrus. Brain Res Bull 18, 533-545.
120. Oitzl, M.S., De Kloet, E.R., Joels, M., Schmid, W., and Cole, T.J. (1997). Spatial learning deficits in mice with a targeted glucocorticoid receptor gene disruption. Eur J Neurosci 9, 2284-2296.
121. Oitzl, M.S., Reichardt, H.M., Joels, M., and De Kloet, E.R. (2001). Point mutation in the mouse glucocorticoid receptor preventing DNA binding impairs spatial memory. Proc Natl Acad Sci U S A 98, 12790-12795.
122. Olton, D.S. (1990). Dementia: animal models of the cognitive impairments following damage to the basal forebrain cholinergic system. Brain Res Bull 25, 499-502.
123. Park, S.J., Shin, E.J., Min, S.S., An, J., Li, Z., Hee Chung, Y., Hoon Jeong, J., Bach, J.H., Nah, S.Y., Kim, W.K., Jang, C.G., Kim, Y.S., Nabeshima, Y., Nabeshima, T., and Kim, H.C. (2013). Inactivation of JAK2/STAT3 signaling axis and downregulation of M1 mAChR cause cognitive impairment in klotho mutant mice, a genetic model of aging. Neuropsychopharmacology 38, 1426-1437.
124. Pitman, D.L., Ottenweller, J.E., and Natelson, B.H. (1988). Plasma corticosterone levels during repeated presentation of two intensities of restraint stress: chronic stress and habituation. Physiol Behav 43, 47-55.
125. Popoli, M., Yan, Z., Mcewen, B.S., and Sanacora, G. (2012). The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci 13, 22-37.
126. Quirion, R., Wilson, A., Rowe, W., Aubert, I., Richard, J., Doods, H., Parent, A., White, N., and Meaney, M.J. (1995). Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired. J Neurosci 15, 1455-1462.
127. Raison, C.L., and Miller, A.H. (2003). When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 160, 1554-1565.
128. Reichardt, H.M., Kaestner, K.H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., and Schutz, G. (1998). DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93, 531-541.
129. Reichardt, H.M., Tuckermann, J.P., Gottlicher, M., Vujic, M., Weih, F., Angel, P., Herrlich, P., and Schutz, G. (2001). Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J 20, 7168-7173.
130. Reul, J.M., and De Kloet, E.R. (1985). Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117, 2505-2511.
131. Reul, J.M., Van Den Bosch, F.R., and De Kloet, E.R. (1987a). Differential response of type I and type II corticosteroid receptors to changes in plasma steroid level and circadian rhythmicity. Neuroendocrinology 45, 407-412.
132. Reul, J.M., Van Den Bosch, F.R., and De Kloet, E.R. (1987b). Relative occupation of type-I and type-II corticosteroid receptors in rat brain following stress and dexamethasone treatment: functional implications. J Endocrinol 115, 459-467.
133. Sanchez-Resendis, O., Medina, A.C., Serafin, N., Prado-Alcala, R.A., Roozendaal, B., and Quirarte, G.L. (2012). Glucocorticoid-cholinergic interactions in the dorsal striatum in memory consolidation of inhibitory avoidance training. Front Behav Neurosci 6, 33.
134. Sapolsky, R.M. (1996). Why stress is bad for your brain. Science 273, 749-750.
135. Sapolsky, R.M., Krey, L.C., and Mcewen, B.S. (1983). Corticosterone receptors decline in a site specific manner in the aged rat brain. Brain Res 289, 235-240.
136. Sapolsky, R.M., Krey, L.C., and Mcewen, B.S. (1984). Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response. Proc Natl Acad Sci U S A 81, 6174-6177.
137. Sapolsky, R.M., Krey, L.C., and Mcewen, B.S. (1985). Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J Neurosci 5, 1222-1227.
138. Sapolsky, R.M., Krey, L.C., and Mcewen, B.S. (1986). The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 7, 284-301.
139. Sapolsky, R.M., Uno, H., Rebert, C.S., and Finch, C.E. (1990). Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 10, 2897-2902.
140. Sarter, M., Bruno, J.P., and Givens, B. (2003). Attentional functions of cortical cholinergic inputs: what does it mean for learning and memory? Neurobiol Learn Mem 80, 245-256.
141. Schacke, H., Docke, W.D., and Asadullah, K. (2002). Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96, 23-43.
142. Scherrer, D., Lach, E., Landry, Y., and Gies, J.P. (1997). Glucocorticoid modulation of muscarinic and beta-adrenergic receptors in guinea pig lung. Fundam Clin Pharmacol 11, 111-116.
143. Silverman, M.N., and Sternberg, E.M. (2012). Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci 1261, 55-63.
144. Simons, S.S., Jr. (2008). What goes on behind closed doors: physiological versus pharmacological steroid hormone actions. Bioessays 30, 744-756.
145. Smith, M.L., and Booze, R.M. (1995). Cholinergic and GABAergic neurons in the nucleus basalis region of young and aged rats. Neuroscience 67, 679-688.
146. Sousa, N., Madeira, M.D., and Paula-Barbosa, M.M. (1998). Effects of corticosterone treatment and rehabilitation on the hippocampal formation of neonatal and adult rats. An unbiased stereological study. Brain Res 794, 199-210.
147. Srinivasan, S., Shariff, M., and Bartlett, S.E. (2013). The role of the glucocorticoids in developing resilience to stress and addiction. Front Psychiatry 4, 68.
148. Steckler, T., Keith, A.B., Wiley, R.G., and Sahgal, A. (1995). Cholinergic lesions by 192 IgG-saporin and short-term recognition memory: role of the septohippocampal projection. Neuroscience 66, 101-114.
149. Teles-Grilo Ruivo, L.M., and Mellor, J.R. (2013). Cholinergic modulation of hippocampal network function. Front Synaptic Neurosci 5, 2.
150. Thorne, B., and Potter, P.E. (1995). Lesion with the neurotoxin AF64A alters hippocampal cholinergic receptor function. Brain Res Bull 38, 121-127.
151. Tornello, S., Orti, E., De Nicola, A.F., Rainbow, T.C., and Mcewen, B.S. (1982). Regulation of glucocorticoid receptors in brain by corticosterone treatment of adrenalectomized rats. Neuroendocrinology 35, 411-417.
152. Torres, N., Fanelli, M., Alvarez, A.L., Santajuliana, D., Finkielman, S., and Pirola, C.J. (1991). Glucocorticoid-induced hypertension in rats: role of the central muscarinic cholinergic system. J Endocrinol 129, 269-274.
153. Tzavara, E.T., Bymaster, F.P., Felder, C.C., Wade, M., Gomeza, J., Wess, J., Mckinzie, D.L., and Nomikos, G.G. (2003). Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice. Mol Psychiatry 8, 673-679.
154. Uno, H., Tarara, R., Else, J.G., Suleman, M.A., and Sapolsky, R.M. (1989). Hippocampal damage associated with prolonged and fatal stress in primates. J Neurosci 9, 1705-1711.
155. Van Der Laan, S., and Meijer, O.C. (2008). Pharmacology of glucocorticoids: beyond receptors. Eur J Pharmacol 585, 483-491.
156. Van Der Zee, E.A., and Keijser, J.N. (2011). Localization of pre- and postsynaptic cholinergic markers in rodent forebrain: a brief history and comparison of rat and mouse. Behav Brain Res 221, 356-366.
157. Van Haarst, A.D., Oitzl, M.S., Workel, J.O., and De Kloet, E.R. (1996). Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity. Endocrinology 137, 4935-4943.
158. Vannucchi, M.G., and Goldman-Rakic, P.S. (1991). Age-dependent decrease in the affinity of muscarinic M1 receptors in neocortex of rhesus monkeys. Proc Natl Acad Sci U S A 88, 11475-11479.
159. Vollmann-Honsdorf, G.K., Flugge, G., and Fuchs, E. (1997). Chronic psychosocial stress does not affect the number of pyramidal neurons in tree shrew hippocampus. Neurosci Lett 233, 121-124.
160. Voss, B., Thienel, R., Reske, M., Habel, U., and Kircher, T. (2010). Cognitive performance and cholinergic transmission: influence of muscarinic and nicotinic receptor blockade. Eur Arch Psychiatry Clin Neurosci 260 Suppl 2, S106-110.
161. Vyas, S., and Maatouk, L. (2013a). Contribution of glucocorticoids and glucocorticoid receptors to the regulation of neurodegenerative processes. CNS Neurol Disord Drug Targets 12, 1175-1193.
162. Vyas, S., and Maatouk, L. (2013b). Contribution of Glucocorticoids and Glucocorticoid Receptors to the Regulation of Neurodegenerative Processes. CNS Neurol Disord Drug Targets.
163. Whitehouse, P.J., Price, D.L., Clark, A.W., Coyle, J.T., and Delong, M.R. (1981). Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10, 122-126.
164. Whitehouse, P.J., Price, D.L., Struble, R.G., Clark, A.W., Coyle, J.T., and Delon, M.R. (1982). Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215, 1237-1239.
165. Wiley, R.G., Oeltmann, T.N., and Lappi, D.A. (1991). Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptor. Brain Res 562, 149-153.
166. Willard, L.B., Hauss-Wegrzyniak, B., and Wenk, G.L. (1999). Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats. Neuroscience 88, 193-200.
167. Yamagami, K., Joseph, J.A., and Roth, G.S. (1992). Decrement of muscarinic receptor-stimulated low-KM GTPase in striatum and hippocampus from the aged rat. Brain Res 576, 327-331.
168. Yang-Yen, H.F., Chambard, J.C., Sun, Y.L., Smeal, T., Schmidt, T.J., Drouin, J., and Karin, M. (1990). Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62, 1205-1215.
169. Zhang, H.Y., Watson, M.L., Gallagher, M., and Nicolle, M.M. (2007). Muscarinic receptor-mediated GTP-Eu binding in the hippocampus and prefrontal cortex is correlated with spatial memory impairment in aged rats. Neurobiol Aging 28, 619-626.